Candida infection in critically ill patients study
Part of Infections clinical trials.
This study looks at patients in the intensive care unit who have a new infection with Candida (a type of fungus) despite taking strong antibiotics. It aims to better understand and diagnose these serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (critically ill).
- You have a new sepsis infection with a fever over 100.4°F (38°C).
- You have Candida fungus found in more than one non-sterile body site.
- Your fever persists after at least 5 days of broad-spectrum antibiotics.
- You have at least one risk factor like recent abdominal surgery, pancreatitis, a central line, or receiving dialysis, steroids, or other treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at Candida infections that are hard to treat, especially when the body's defenses are weak or after medical procedures. It aims to understand why some Candida become resistant to antifungal medicines and form protective layers called biofilms.
This trial monitors a marker of immune function (monocyte HLA-DR) in patients with severe abdominal infections that may lead to fungal infections. It aims to see if this marker can help guide treatment.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.
This study looks at different types of fungi that may cause serious lung infections in patients with weakened immune systems in the ICU. It aims to find out which fungi are present and which antifungal drugs can kill them.
Hear when a new Invasive Candidiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.